• • • • Review practice agreements in your state. Identify whether your state requires physician collaboration or supervision for nurse practitioners, and if so, what those requirements are. Research the following: o How do you get certified and licensed as an Advanced Practice Registered Nurse (APRN) in your state? o What is the application process for certification in your state? o What is your state’s board of nursing website? o How does your state define the scope of practice of a nurse practitioner? o What is included in your state practice agreement? o How do you get a DEA license? o Does your state have a prescription monitoring program (PMP)? o How does your state describe a nurse practitioner’s controlled-substance prescriptive authority, and what nurse practitioner drug schedules are nurse practitioners authorized to prescribe? Post a summary of your findings on your state based on the questions listed above. Explain the types of regulations that exist and the barriers that may impact nurse practitioner independent practice in your state. Be specific. Also, describe what surprised you from your research.(My State is Maryland)
Free features
Title Page
$10.00
FREE
Outline
$10.00
FREE
Revisions
$10.00
FREE
Formatting
$10.00
FREE
Best Writer
$10.00
FREE
Order Now
Recent posts
- With the rise of telemedicine and on-demand health services, I’ve been wondering how effective it is to https://aimshealthcare.ae/service/doctor-at-home-du
- TOPIC: PNEUMONIA PATIENT: 68 Y/O FEMALE? CHIEF COMPLAINT: COUGH AND FEVER ICD10 : J18.9 PLEASE I ATTACHED THE TEMPLATE FOR YOU BE ABLE TO CREATE A SOAP NOT
- TOPIC: HYPERTENSION PATIENT: 64 Y/O FEMALE? CHIEF COMPLAINT: BLOOD PRESSURE FOLLOW UP ICD10 : I10 PLEASE I ATTACHED THE TEMPLATE FOR YOU BE ABLE TO CREATE
- TOPIC: CONJUCTIVITIS PATIENT: 32 Y/O MALE? CHIEF COMPLAINT: MY LEFT EYE IS HURTING ICD10 : H10.021 PLEASE I ATTACHED THE TEMPLATE FOR YOU BE ABLE TO CREATE
- The CMS considers patient engagement a quality metric for a learning healthcare system. ?? Patient engagement is a major focal point of stage 2 MU of?HER.